GT Biopharma Inc. (GTBP)
NASDAQ: GTBP
· Real-Time Price · USD
1.49
0.15 (11.19%)
At close: Aug 18, 2025, 10:48 AM
GT Biopharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.62 | -0.38 | -0.38 | -0.31 | -0.66 | -0.89 | -1.02 | -1.57 | -19.66 | -1.41 | -16.6 | -7.84 | -4.3 | -10.98 | -9.7 | -26.71 | -0.94 |
PEG Ratio | 0.02 | -0.01 | 0.01 | -0.01 | 0.03 | -0.04 | -0.05 | -0.00 | 0.21 | -0.00 | 0.23 | 0.18 | -0.03 | 0.18 | -0.49 | 0.29 | -0.00 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -5.14 | -3.46 | 2.46 | 0.83 | 1.12 | 1.41 | 0.99 | 1.07 | 1.37 | 2.68 | 28.63 | 6.05 | 5.26 | 36.13 | 6.60 | 14.25 | 4.59 |
P/FCF Ratio | -2.29 | -2.34 | -1.89 | -1.29 | -1.43 | -5.16 | -5.03 | -6.48 | -6.14 | -7.31 | -156.54 | -33.52 | -17.94 | -213.65 | -53.83 | -121.13 | -30.15 |
P/OCF Ratio | -2.29 | -2.34 | -1.89 | -1.29 | -1.43 | -5.16 | -5.03 | -6.48 | -6.14 | -7.31 | -156.54 | -33.52 | -17.94 | -213.65 | -53.83 | -121.13 | -30.15 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 0.73 | 0.72 | 1.45 | 2.47 | 2.15 | 2.12 | 3.15 | 3.72 | 4.89 | 3.35 | 4.15 | 2.78 | 2.86 | 3.14 | 9.13 | 12.08 | 7.62 |
Current Ratio | 0.73 | 0.72 | 1.45 | 2.47 | 2.15 | 2.12 | 3.15 | 3.72 | 4.89 | 3.35 | 4.15 | 2.78 | 2.86 | 3.14 | 9.13 | 12.08 | 7.62 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.62K | -17.29 | -722.25 | n/a | n/a | n/a | -826.27 | n/a | n/a | -41.67 |
Return on Equity | 0.79 | 2.26 | -1.63 | -0.67 | -0.43 | -0.4 | -0.24 | -0.17 | -0.02 | -0.48 | -0.43 | -0.19 | -0.31 | -0.82 | -0.17 | -0.13 | -1.23 |
Return on Assets | -0.29 | -0.89 | -0.5 | -0.4 | -0.23 | -0.21 | -0.15 | -0.11 | -0.01 | -0.33 | -0.33 | -0.12 | -0.2 | -0.56 | -0.15 | -0.12 | -1.07 |
Return on Invested Capital | 1.97 | 2.25 | -1.72 | -0.71 | -0.58 | -0.42 | -0.28 | -0.27 | -0.23 | -0.49 | -0.43 | -0.19 | -0.3 | -0.83 | -0.19 | -0.12 | -1.21 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |